ips 339 has been researched along with pindolol in 1 studies
| Studies (ips 339) | Trials (ips 339) | Recent Studies (post-2010) (ips 339) | Studies (pindolol) | Trials (pindolol) | Recent Studies (post-2010) (pindolol) |
|---|---|---|---|---|---|
| 26 | 0 | 0 | 3,718 | 662 | 92 |
| Protein | Taxonomy | ips 339 (IC50) | pindolol (IC50) |
|---|---|---|---|
| Beta-2 adrenergic receptor | Homo sapiens (human) | 0.0005 | |
| Beta-1 adrenergic receptor | Homo sapiens (human) | 0.0009 | |
| Beta-3 adrenergic receptor | Homo sapiens (human) | 0.088 | |
| 5-hydroxytryptamine receptor 1A | Rattus norvegicus (Norway rat) | 0.048 | |
| 5-hydroxytryptamine receptor 1B | Rattus norvegicus (Norway rat) | 0.048 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (100.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Dattel, BJ; Lam, F; Roberts, JM | 1 |
1 other study(ies) available for ips 339 and pindolol
| Article | Year |
|---|---|
Failure to demonstrate decreased beta-adrenergic receptor concentration or decreased agonist efficacy in term or preterm human parturition.
Topics: Adrenergic beta-Agonists; Binding, Competitive; Female; Humans; Iodocyanopindolol; Isoproterenol; Labor, Obstetric; Myometrium; Obstetric Labor, Premature; Pindolol; Pregnancy; Propanolamines; Radioligand Assay; Receptors, Adrenergic, beta | 1986 |